{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T20:09:37Z","timestamp":1784232577401,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.intimp.2026.117038","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T12:27:01Z","timestamp":1781958421000},"page":"117038","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["LGALS1 promotes the malignant progression and sunitinib resistance of clear cell renal cell carcinoma by reprogramming fatty acid metabolism"],"prefix":"10.1016","volume":"185","author":[{"given":"Sichen","family":"Di","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keqiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangchun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haimin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.intimp.2026.117038_bb0005","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s11523-019-00653-5","article-title":"Sunitinib for metastatic renal cell carcinoma: a systematic review and Meta-analysis of real-world and clinical trials data","volume":"14","author":"Moran","year":"2019","journal-title":"Target. Oncol."},{"issue":"2","key":"10.1016\/j.intimp.2026.117038_bb0010","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJMoa065044","article-title":"Sunitinib versus interferon alfa in metastatic renal-cell carcinoma","volume":"356","author":"Motzer","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2026.117038_bb0015","first-page":"54","article-title":"Recent progress on tyrosine kinase inhibitors resistance in renal cell carcinoma: another brick in the wall?","volume":"8","author":"Dong","year":"2025","journal-title":"Cancer drug resistance (Alhambra, Calif)."},{"issue":"1","key":"10.1016\/j.intimp.2026.117038_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11010001","article-title":"Metabolomic analysis to elucidate mechanisms of Sunitinib resistance in renal cell carcinoma","volume":"11","author":"Sato","year":"2020","journal-title":"Metabolites"},{"issue":"7","key":"10.1016\/j.intimp.2026.117038_bb0025","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41419-024-06913-1","article-title":"DEPDC1 as a metabolic target regulates glycolysis in renal cell carcinoma through AKT\/mTOR\/HIF1\u03b1 pathway","volume":"15","author":"Di","year":"2024","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.intimp.2026.117038_bb0030","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ccell.2015.12.004","article-title":"An integrated metabolic atlas of clear cell renal cell carcinoma","volume":"29","author":"Hakimi","year":"2016","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.intimp.2026.117038_bb0035","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2013.05.017","article-title":"Cellular fatty acid metabolism and cancer","volume":"18","author":"Currie","year":"2013","journal-title":"Cell Metab."},{"issue":"7381","key":"10.1016\/j.intimp.2026.117038_bb0040","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nature10642","article-title":"Reductive carboxylation supports growth in tumour cells with defective mitochondria","volume":"481","author":"Mullen","year":"2011","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.intimp.2026.117038_bb0045","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrc2222","article-title":"Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis","volume":"7","author":"Menendez","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.intimp.2026.117038_bb0050","article-title":"FADS3 fuels CcRCC progression via lipid-droplet\/TGF-\u03b2 receptors axis bridging metabolic reprogramming and epithelial plasticity","author":"Sun","year":"2025","journal-title":"International Journal of Surgery (London, England)"},{"key":"10.1016\/j.intimp.2026.117038_bb0055","first-page":"0539","article-title":"STAT2\/SLC27A3\/PINK1-mediated Mitophagy remodeling lipid metabolism contributes to Pazopanib resistance in clear cell renal cell carcinoma","volume":"7","author":"Lu","year":"2024","journal-title":"Research (Washington, DC)."},{"issue":"23","key":"10.1016\/j.intimp.2026.117038_bb0060","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1158\/0008-5472.CAN-23-0969","article-title":"Fatty acid oxidation mediated by Malonyl-CoA decarboxylase represses renal cell carcinoma progression","volume":"83","author":"Zhou","year":"2023","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.intimp.2026.117038_bb0065","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/1471-2105-15-293","article-title":"jvenn: an interactive Venn diagram viewer","volume":"15","author":"Bardou","year":"2014","journal-title":"BMC bioinformatics."},{"issue":"W1","key":"10.1016\/j.intimp.2026.117038_bb0070","doi-asserted-by":"crossref","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.intimp.2026.117038_bb0075","series-title":"Proteomics. Tissue-Based Map of the Human Proteome. Science (New York, NY)","author":"Uhl\u00e9n","year":"2015"},{"issue":"1","key":"10.1016\/j.intimp.2026.117038_bb0080","article-title":"BEST: a web application for comprehensive biomarker exploration on large-scale data in solid tumors","volume":"10","author":"Liu","year":"2023","journal-title":"J Big Data-Ger."},{"key":"10.1016\/j.intimp.2026.117038_bb0085","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ebiom.2018.12.011","article-title":"Gankyrin is a novel biomarker for disease progression and prognosis of patients with renal cell carcinoma","volume":"39","author":"Wang","year":"2019","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.intimp.2026.117038_bb0090","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12943-022-01549-1","article-title":"N(6)-methyladenosine-modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14-dependent manner in renal cell carcinoma","volume":"21","author":"Chen","year":"2022","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2026.117038_bb0095","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41419-023-05566-w","article-title":"Single-cell RNA-seq integrated with multi-omics reveals SERPINE2 as a target for metastasis in advanced renal cell carcinoma","volume":"14","author":"Chen","year":"2023","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.intimp.2026.117038_bb0100","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/cac2.12341","article-title":"PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism","volume":"42","author":"Dai","year":"2022","journal-title":"Cancer communications (London, England)."},{"issue":"6","key":"10.1016\/j.intimp.2026.117038_bb0105","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.jhep.2015.07.039","article-title":"CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt\/mTOR\/SREBP1c and P38\/PPAR\u03b1 pathways","volume":"63","author":"Li","year":"2015","journal-title":"J. Hepatol."},{"issue":"10","key":"10.1016\/j.intimp.2026.117038_bb0110","first-page":"e2304702","article-title":"Induction of fatty acid oxidation underlies DNA damage-induced cell death and ameliorates obesity-driven chemoresistance","volume":"vol. 11","author":"Hwang","year":"2024","journal-title":"Advanced Science (Weinheim, Baden-Wurttemberg, Germany)"},{"key":"10.1016\/j.intimp.2026.117038_bb0115","article-title":"Metabolic pathways in kidney Cancer: current therapies and future directions. Journal of clinical oncology\u202f: official journal of the American society of","author":"Rathmell","year":"2018","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.intimp.2026.117038_bb0120","doi-asserted-by":"crossref","first-page":"1664292","DOI":"10.3389\/fcell.2025.1664292","article-title":"Emerging roles of metabolic biomarkers in renal cell carcinoma: from molecular mechanisms to clinical implications","volume":"13","author":"Yang","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117038_bb0125","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nrc1527","article-title":"Galectins as modulators of tumour progression","volume":"5","author":"Liu","year":"2005","journal-title":"Nat. Rev. Cancer"},{"issue":"7","key":"10.1016\/j.intimp.2026.117038_bb0130","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.7113","article-title":"Effect of galectin-1 on prognosis and responsiveness of immune checkpoint plus tyrosine kinase inhibition in renal cell carcinoma","volume":"13","author":"Wang","year":"2024","journal-title":"Cancer Med."},{"issue":"3","key":"10.1016\/j.intimp.2026.117038_bb0135","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s12253-019-00710-4","article-title":"Unraveling LGALS1 as a potential immune checkpoint and a predictor of the response to anti-PD1 therapy in clear cell renal carcinoma","volume":"26","author":"Li","year":"2020","journal-title":"Pathology oncology research\u202f: POR."},{"issue":"5","key":"10.1016\/j.intimp.2026.117038_bb0140","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/bjc.2013.828","article-title":"Galectin-1 has potential prognostic significance and is implicated in clear cell renal cell carcinoma progression through the HIF\/mTOR signaling axis","volume":"110","author":"White","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"7","key":"10.1016\/j.intimp.2026.117038_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110415","article-title":"Decoding sunitinib resistance in ccRCC: metabolic-reprogramming-induced ABAT and GABAergic system shifts","volume":"27","author":"Zhang","year":"2024","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.intimp.2026.117038_bb0150","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/15384101.2024.2306760","article-title":"Impact of sunitinib resistance on clear cell renal cell carcinoma therapeutic sensitivity in vitro","volume":"23","author":"Ghosh","year":"2024","journal-title":"Cell cycle (Georgetown, Tex)."},{"issue":"7","key":"10.1016\/j.intimp.2026.117038_bb0155","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/s41419-024-06865-6","article-title":"A novel LGALS1-depended and immune-associated fatty acid metabolism risk model in acute myeloid leukemia stem cells","volume":"15","author":"Qin","year":"2024","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.intimp.2026.117038_bb0160","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.molmet.2014.02.002","article-title":"Integrated physiology and systems biology of PPAR\u03b1","volume":"3","author":"Kersten","year":"2014","journal-title":"Molecular metabolism."},{"issue":"3","key":"10.1016\/j.intimp.2026.117038_bb0165","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41588-024-01662-5","article-title":"Multi-omic profiling of clear cell renal cell carcinoma identifies metabolic reprogramming associated with disease progression","volume":"56","author":"Hu","year":"2024","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.intimp.2026.117038_bb0170","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","article-title":"xCell: digitally portraying the tissue cellular heterogeneity landscape","volume":"18","author":"Aran","year":"2017","journal-title":"Genome Biol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926008842?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926008842?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T19:31:51Z","timestamp":1784230311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926008842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":34,"alternative-id":["S1567576926008842"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117038","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LGALS1 promotes the malignant progression and sunitinib resistance of clear cell renal cell carcinoma by reprogramming fatty acid metabolism","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117038"}}